Sterigenics International invests US$10m in expansion in US and Europe
Will add ethylene oxide chambers at plants in Smyrna, Georgia, Grand Prairie, Texas and Petit-Rechain, Belgium
Sterigenics International, an outsourced contract sterilisation services specialist, will invest more than US$10m to expand operations in Atlanta and Dallas in the US and in Petit-Rechain, Belgium as a result of increasing customer demand.
The Sterigenics Atlanta facility, located for more than 20 years in Smyrna, Georgia, will add a 30-pallet ethylene oxide chamber, increasing processing capacity 2mft3 a year. An additional aeration room will accommodate the increased production. Sterilisation of medical products, validation capabilities and SteriPro lab services are offered at the site.
The Sterigenics Dallas facility, located in Grand Prairie, Texas, will increase ethylene oxide processing capacity by 3mft3 a year. Here, pre-conditioning and aeration rooms will be expanded, with completion by January 2015. Sterigenics has operated at the site since 2003 and offers sterilisation of medical products, validation capabilities and SteriPro lab services.
Petit-Rechain, Belgium is one of Sterigenics largest locations, offering ethylene oxide sterilisation, SteriPro lab services, validation and cycle development capabilities. The company will install a 32-pallet chamber at this facility, bringing the total number of chambers to 14. The new chamber will add 2mft3 of additional ethylene oxide processing capacity and will be operational by the end of the year.
Headquartered in Deerfield, Illinois, Sterigenics International has 40 facilities across the Americas, Europe and Asia, offering outsourced contract sterilisation services, primarily to the medical device, pharmaceutical, food safety and high performance/specialist materials industries.